贝伐珠单抗应用于非小细胞肺癌中的研究进展

目前，非小细胞肺癌是世界癌症相关死亡的重要原因之一，发病率逐年增加。该现状促使人们寻求更加有效的治疗手段来延长患者的生存期，改善患者的生存质量。本文通过综述相关的临床数据，总结贝伐珠单抗在非小细胞肺癌中的应用，探讨贝伐珠单抗临床使用的有效性、可能出现的不良事件、未来发展方向。

Research progress of bevacizumab in non-small cell lung cancer

At present,non-small cell lung cancer(NSCLC) is one of the important causes of cancer-related death in the world,and its incidence has been increased year by year.This situation has prompted people to seek more effective therapy to extend the survival of patients and improve their quality of life.This article reviews relevant clinical data,summarizes the application of bevacizumab in NSCLC,and discusses the effectiveness of clinical use of bevacizumab,potential adverse events,and future development directions.